|
CN106146545A
|
|
A kind of preparation method of antibiotic medicine intermediate
|
|
CN105906529A
|
|
4-halogenated-2-diazo-3-oxo-valeric acid(4-nitrobenzene)methyl ester and preparation method thereof
|
|
CN106008222A
|
|
Preparation method for 4-halo-3-oxo-pentanoic acid-(4-nitrobenzene)methyl ester and product thereof
|
|
CN105859746A
|
|
Synthesis method for aspoxicillin
|
|
CN105753885A
|
|
Aspoxicillin synthesis process
|
|
CN105503875A
|
|
Synthesis method of tenofovir disoproxil fumarate intermediate impurity
|
|
CN105130806A
|
|
Method of reducing impurities in synthesis process of emtricitabine intermediate MGH
|
|
CN105017158A
|
|
Preparation method of cis-rosuvastatin calcium impurity
|
|
CN105021730A
|
|
Method for detecting Tenofovir optical antimers by high performance liquid chromatography
|
|
CN105153039A
|
|
Preparation method for rosuvastatin calcium intermediate impurity
|
|
CN104844525A
|
|
Preparation method of rosuvastatin calcium impurity
|
|
CN104530039A
|
|
Method for preparing piperacillin impurity C
|
|
CN104529909A
|
|
Crystallization method of rosuvastatin calcium intermediate
|
|
CN104529914A
|
|
Synthesizing and purifying methods of 4, 4'-carbonyl di-1-ethyl piperazine-2, 3-dione
|
|
CN104530050A
|
|
Synthesis method of tenofovir disoproxil fumarate intermediate impurity 1-amino adenine-2-propyl alcohol
|
|
CN104262359A
|
|
Synthetic method of salbactam acid
|
|
CN103044447A
|
|
Preparation method of benzhydryl s-oxopenicillanate
|
|
CN102993064A
|
|
Preparation and crystallization method of (2S)-2-animo-3-methyl-3-sulfinobutanoic acid
|
|
CN102977120A
|
|
Method for preparing and crystallizing sulbactam pivoxyl
|
|
CN102977119A
|
|
Process for preparing piperacillin sodium by using solvent method
|
